Comparative efficacy of intralesional sodium stibogluconate (SSG) alone and its combination with intramuscular SSG to treat localized cutaneous leishmaniasis: Results of a pilot study

Indian Journal of Dermatology, Venereology and Leprology

Volumn 73, Issue 4, 2007, Pages 280-

  Negi, Ajeet K ^a   Sharma, Nand Lal ^a   Mahajan, Vikram K ^a   Ranjan, Nitin ^a   Kanga, Anil K ^a  

^a INDIRA GANDHI MEDICAL COLLEGE   (India)

Author keywords

Intralesional sodium stibogluconate; Intramuscular sodium stibogluconate; Localized cutaneous leishmaniasis

Indexed keywords

STIBOGLUCONATE SODIUM;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOSE CALCULATION; DRUG EFFICACY; FOLLOW UP; HEALING; HUMAN; MULTIPLE CYCLE TREATMENT; PILOT STUDY; SKIN DEFECT; SKIN LEISHMANIASIS; SKIN NODULE;

EID: 34547650593     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.33651     Document Type: Article

References (23)

1. World Health Organization. Epidemiological aspects. In control of the leishmaniasis, WHO Tech Rep Ser.793. World Health Organization: Geneva; 1990. p. 41-6.
2. Herwaldt BL, Stokes SL, Juranek DD. American cutaneous leishmaniasis in US travelers. Ann Intern Med 1993;118:779-84.
3. Sharma RC, Mahajan VK, Sharma NL, Sharma A. A new focus of Cutaneous leishmaniasis in Himachal Pradesh (India). Indian J Dermatol Venereol Leprol 2003;69:170-2.
4. Goddard J. Leishmaniasis. Infect Med 1999;16:566-9.
5. Mess JT, Wilson JP. Current treatment recommendations for leishmaniasis. Ann Pharmaco Ther 1992;26:1452-5.
6. Tallab TM, Bahamdam KA, Mirdad S, Johargi H, Mourad MM, Ibrahim K, et al. Cutaneous leishmaniasis: Schedules for intralesional treatment with sodium stibogluconate. Int J Dermatol 1996;35:594-7.
7. Sharquie KE, Al-Talib KK, Chu AC. Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony. Br J Dermatol 1988;119:53-7.
8. Sharma NL, Mahajan VK, Kanga A, Sood A, Katoch VM, Mauricio I, et al. Localized Cutaneous Leishmaniasis due to Leishmania donovani and Leishmania tropica: Preliminary finding of the study of 161 new cases from a new focus in Himachal Pradesh, India. Am J Trop Med Hyg 2005;72:819-24.
9. Parks A, Camisa C. Sporotrichoid leishmaniasis: Report of a case in an American graduate student. J Am Acad Dermatol 1987;17:855-6.
10. Peters W, Evan DA, Lanham SM. Importance of parasite identification in cases of leishmaniasis. J Roy Soc Med 1983;76:540-2.
11. Schnur LF, Chance ML, Ebert F, Thomas SC, Peter SW. The biochemical and serological taxonomy of visceralizing Leishmania. Ann Trop Med Parasitol 1981;75:131-44.
12. Nuwayri-Salti N, Salman S, Shahin NM, Malak J. Leishmania donovani invasion of the blood in a child with dermal leishmaniasis. Ann Trop Paediatr 1999;19:61-4.
13. Nuwayri-Salti N, Muatassem D, Salman S, Izzedine N, Kibbi G. Chornic cutaneous leishmaniasis: Leishmania parasites in blood. Int J Dermatol 1992;31:562-4.
14. Sharma NL, Mahajan VK, Negi AK. Epidemiology of the new focus of localized cutaneous leishmaniasis in Himachal Pradesh (India). J Commun Dis 2005;37:275-9.
15. Momeni AZ, Aminjavahery M. Clinical picture of cutaneous leishmaniasis in Isfahan, Iran. Int J Dermatol 1994;33:260-5.
16. Kubba R, AI-Gindan Y. Some recent observation in cutaneous leishmaniasis. Indian J Dermatol Venereol Leprol 1989;55:7-17.
17. World Health Organization, Control of leishmaniasis. WHO Tech Rep Ser.793. World Health Organization: Geneva; 1990. p. 66-94.
18. Kellum RE. Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (Pentostam). J Am Acad Dermatol 1986;15:620-2.
19. Chulay JD, Spencer HG, Mugambi M. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate). Am J Trop Med Hyg 1985;34:702-9.
20. Brummitt CF, Porter JA, Herwaldt BL. Reversible peripheral neuropathy associated with sodium stibogluconate therapy for American cutaneous leishmaniasis. Clin Infect Dis 1996;22:878-9.
21. Mallick BK. Hypoplasia of bone marrow secondary to sodium antimony gluconate. J Assoc Physicians India 1990;38:310-1.
22. Rai US, Kumar H, Kumar U. Renal dysfunction in patients of kala azar treated with sodium antimony gluconate. J Assoc Physicians India 1994;42:383.
23. nd ed. Massachusetts, Blackwell Scientific Publications; 1992. p. 293-312.